CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dbv Technologies - ADR Company Snapshot
Dbv Technologies operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dbv Technologies with three other companies in this sector in the United States: Neos Therapeutics Inc (2016 sales of $9.15 million of which 100% was Pharmaceutical), Dynavax Technologies Corporation ($11.04 million of which 100% was Biopharmaceutical Product), and Soligenix, Incorporation ($10.45 million of which 100% was Vaccines/BioDefense).

Sales Analysis. Dbv Technologies reported sales of $10.03 million for the year ending December of 2016. This represents an increase of 47.4% versus 2015, when the company's sales were $6.80 million. Sales at Dbv Technologies have increased during each of the previous five years (and since 2011, sales have increased a total of 5,591%).
   
   
 
  Stock Performance Chart for Dbv Technologies - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 25.05
(Figures in U.S. Dollars)
1 Week -4.7%   13 Weeks 7.1%  
4 Weeks -47.9%   52 Weeks -26.6%  
 
Dbv Technologies - ADR Key Data:
  Ticker: DBVT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 10,026,283
(Year Ending Jan 2017).
Employees: 164
  Currency: U.S. Dollars Market Cap: 1,251,219,644
  Fiscal Yr Ends: December Shares Outstanding: 49,948,888
  Share Type: Common Closely Held Shares: 2,006,136
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.